Management of Oligodendroglioma Patients

Muhammad Miftahussurur, Ugroseno, Amie Ashariati


Oligodendroglioma is a neuroepithelial tissue tumor of glioma type and responds well to chemotherapy. Oligodendroglioma tends to invade leptomeninges. Further metastases of cerebrospinal fluid occur in 1-2% of cases. The prognosis of patients with oligodendroglioma is varied, depending on the grade they are experiencing. Progression to anaplasia may occur, even though the frequency is lower than astrocytoma. The diagnosis of oligodendroglioma is based on light microscope examination, and is often difficult to distinguish from astrocytoma. A case of a low-grade oligodendroglioma patient is reported. Special attention is required in this grade, as it can progress slowly but progressively with manifestations only in the form of partial seizures that occur for years. The diagnosis is based on several clinical, radiological signs and is supported by anatomical pathology examination. This patient was given temozolomide (TMZ) chemotherapy for 6 cycles and radiotherapy after resection surgery. The patient survived until 28 months without tumor residue or a new tumor


Paper Citation

in Harvard Style

Miftahussurur M., Ugroseno. and Ashariati A. (2017). Management of Oligodendroglioma Patients.In Proceedings of the International Meeting on Regenerative Medicine - Volume 1: IMRM, ISBN 978-989-758-334-6, pages 406-412. DOI: 10.5220/0007322304060412

in Bibtex Style

author={Muhammad Miftahussurur and Ugroseno and Amie Ashariati},
title={Management of Oligodendroglioma Patients},
booktitle={Proceedings of the International Meeting on Regenerative Medicine - Volume 1: IMRM,},

in EndNote Style


JO - Proceedings of the International Meeting on Regenerative Medicine - Volume 1: IMRM,
TI - Management of Oligodendroglioma Patients
SN - 978-989-758-334-6
AU - Miftahussurur M.
AU - Ugroseno.
AU - Ashariati A.
PY - 2017
SP - 406
EP - 412
DO - 10.5220/0007322304060412